Literature DB >> 3190540

Pars plana vitrectomy in the management of complications of proliferative sickle retinopathy.

J S Pulido1, H W Flynn, J G Clarkson, G W Blankenship.   

Abstract

Ten patients (11 eyes) with sickle-C hemoglobinopathy with complications of proliferative sickle retinopathy were treated using pars plana vitrectomy with or without the use of a scleral buckle. Postoperative visual acuity was improved in ten of 11 cases. Three cases of retinal detachment were managed by internal vitreoretinal techniques alone without the use of a scleral buckle. Although exchange transfusions were used in only five of the 11 cases, no cases of recognized anterior segment ischemia occurred during the postoperative course of these patients. Because of exchange transfusion risks and awareness of intraoperative and postoperative measures to reduce this complication, the use of exchange transfusions probably should be discontinued as prophylaxis for vitreoretinal surgery in these patients.

Entities:  

Mesh:

Year:  1988        PMID: 3190540     DOI: 10.1001/archopht.1988.01060140721042

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  A comparison of 23-gauge and 20-gauge vitrectomy for proliferative sickle cell retinopathy - clinical outcomes and surgical management.

Authors:  Jason Ho; Anna Grabowska; Marta Ugarte; Mahiul Mk Muqit
Journal:  Eye (Lond)       Date:  2018-05-22       Impact factor: 3.775

2.  Vitreoretinal management and surgical outcomes in proliferative sickle retinopathy: a case series.

Authors:  Royce W S Chen; Harry W Flynn; Wen-Hsiang Lee; D Wilkin Parke; Ryan F Isom; Janet L Davis; William E Smiddy
Journal:  Am J Ophthalmol       Date:  2013-12-31       Impact factor: 5.258

Review 3.  The past, present and future management of sickle cell retinopathy within an African context.

Authors:  Kwesi Nyan Amissah-Arthur; Evelyn Mensah
Journal:  Eye (Lond)       Date:  2018-07-10       Impact factor: 3.775

Review 4.  Surgical and Medical Perioperative Management of Sickle Cell Retinopathy: A Literature Review.

Authors:  Harrish Nithianandan; Jayanth Sridhar
Journal:  Int Ophthalmol Clin       Date:  2020
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.